Approval · Notice of Compliance 12871 · 2011
HALAVEN: Notice of Compliance 12871
Issued December 14, 2011
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 12871
- Date
- December 14, 2011
- Company
- Eisai LimitedWoodcliff Lake, New Jersey, United States
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- Antineoplastic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| HALAVEN | 02377438 | Marketed |
Medicinal ingredients
- ERIBULIN MESYLATE 0.5 MG per ML